文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

输血依赖型和非输血依赖型地中海贫血的血液流变学特征及慢性炎症标志物

Hemorheological profiles and chronic inflammation markers in transfusion-dependent and non-transfusion- dependent thalassemia.

作者信息

Caprari Patrizia, Profumo Elisabetta, Massimi Sara, Buttari Brigitta, Riganò Rachele, Regine Vincenza, Gabbianelli Marco, Rossi Stefania, Risoluti Roberta, Materazzi Stefano, Gullifa Giuseppina, Maffei Laura, Sorrentino Francesco

机构信息

National Centre for the Control and Evaluation of Medicines, Istituto Superiore di Sanità, Rome, Italy.

Department of Cardiovascular and Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy.

出版信息

Front Mol Biosci. 2023 Jan 9;9:1108896. doi: 10.3389/fmolb.2022.1108896. eCollection 2022.


DOI:10.3389/fmolb.2022.1108896
PMID:36699704
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9868635/
Abstract

The rheological properties of blood play an important role in regulating blood flow in micro and macro circulation. In thalassemia syndromes red blood cells exhibit altered hemodynamic properties that facilitate microcirculatory diseases: increased aggregation and reduced deformability, as well as a marked increase in adherence to the vascular endothelial cells. A personalized approach to treating thalassemia patients (transfusions, iron chelation, and splenectomy), has increased patients' life expectancy, however they generally present many complications and several studies have demonstrated the presence of high incidence of thromboembolic events. In this study the hemorheological profiles of thalassemia patients have been characterized to point out new indices of vascular impairment in thalassemia. Plasma viscosity, blood viscosities at low and high shear rates (η1 and η200, respectively), erythrocyte aggregation index (η1/η200), and the erythrocyte viscoelastic profile (elastic modulus G', and viscous modulus G") have been studied in transfusion-dependent and non-transfusion-dependent thalassemia patients. Moreover, the levels of inflammation biomarkers in thalassemia have been evaluated to investigate a relationship between the biomarkers, the disease severity and the rheological parameters. The biomarkers studied are the main components of the immune and endothelial systems or are related to vascular inflammation: cytokines (IL-2, IL-6, IL-10, IL-17A, TNF-alpha), chemokines (IL-8, MIP-1alpha), adipocytokines (leptin and adiponectin), growth factors (VEGF, angiopoietin-1), adhesion molecules (ICAM-1, VCAM-1, E-selectin, L-selectin), and a monocyte/macrophage activation marker (CD163). This study shows that transfusion-dependent thalassemia patients, both major and intermedia, have blood viscosities comparable to those of healthy subjects. Non-transfusion-dependent thalassemia intermedia patients show high blood viscosities at low shear rates (η1), corresponding to the flow conditions of the microcirculation, an increase in erythrocyte aggregation, and high values of the elastic G' and viscous G" modules that reflect a reduced erythrocyte deformability and an increase in blood viscosity. Levels of cytokines, chemokines and adhesion molecules are different in transfusion- and non-transfusion dependent patients and positive correlations between η1 or η1/η200 and the cytokines IL-6 and IL-10 have been observed. The evaluation of the hemorheological profiles in thalassemia can provide new indicators of vascular impairment and disease severity in thalassemia in order to prevent the onset of thromboembolic events.

摘要

血液的流变学特性在调节微循环和大循环中的血流方面起着重要作用。在地中海贫血综合征中,红细胞表现出血流动力学特性改变,这易引发微循环疾病:聚集性增加、可变形性降低,以及与血管内皮细胞的黏附显著增加。针对地中海贫血患者的个性化治疗方法(输血、铁螯合和脾切除术)提高了患者的预期寿命,然而他们通常会出现许多并发症,并且多项研究已证明血栓栓塞事件的发生率很高。在本研究中,对地中海贫血患者的血液流变学特征进行了表征,以指出地中海贫血中血管损伤的新指标。研究了依赖输血和非依赖输血的地中海贫血患者的血浆黏度、低剪切率和高剪切率下的血液黏度(分别为η1和η200)、红细胞聚集指数(η1/η200)以及红细胞黏弹性特征(弹性模量G'和黏性模量G")。此外,还评估了地中海贫血中炎症生物标志物的水平,以研究生物标志物、疾病严重程度和流变学参数之间的关系。所研究的生物标志物是免疫和内皮系统的主要成分或与血管炎症相关:细胞因子(IL-2、IL-6、IL-10、IL-17A、TNF-α)、趋化因子(IL-8、MIP-1α)、脂肪细胞因子(瘦素和脂联素)、生长因子(VEGF、血管生成素-1)、黏附分子(ICAM-1、VCAM-1、E-选择素、L-选择素)以及单核细胞/巨噬细胞活化标志物(CD163)。本研究表明,依赖输血的重型和中间型地中海贫血患者的血液黏度与健康受试者相当。非依赖输血的中间型地中海贫血患者在低剪切率(η1)下表现出高血液黏度,这与微循环的血流条件相对应,红细胞聚集增加,弹性G'和黏性G"模块值较高,这反映了红细胞可变形性降低和血液黏度增加。输血依赖和非输血依赖患者的细胞因子、趋化因子和黏附分子水平不同,并且观察到η1或η1/η200与细胞因子IL-6和IL-10之间存在正相关。评估地中海贫血患者的血液流变学特征可为地中海贫血中的血管损伤和疾病严重程度提供新指标,以预防血栓栓塞事件的发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cda6/9868635/f84372e3a755/fmolb-09-1108896-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cda6/9868635/06d1f43bd6a3/fmolb-09-1108896-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cda6/9868635/71c6697532f1/fmolb-09-1108896-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cda6/9868635/05f9c5787171/fmolb-09-1108896-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cda6/9868635/f84372e3a755/fmolb-09-1108896-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cda6/9868635/06d1f43bd6a3/fmolb-09-1108896-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cda6/9868635/71c6697532f1/fmolb-09-1108896-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cda6/9868635/05f9c5787171/fmolb-09-1108896-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cda6/9868635/f84372e3a755/fmolb-09-1108896-g004.jpg

相似文献

[1]
Hemorheological profiles and chronic inflammation markers in transfusion-dependent and non-transfusion- dependent thalassemia.

Front Mol Biosci. 2023-1-9

[2]
Effect of hemorheological parameters on myocardial injury after primary or elective percutaneous coronary intervention.

Coron Artery Dis. 2018-12

[3]
Soluble endothelial adhesion molecules and inflammation markers in patients with beta-thalassemia intermedia.

Blood Cells Mol Dis. 2009

[4]
Hemorheological Alterations and Oxidative Damage in Sickle Cell Anemia.

Front Mol Biosci. 2019-12-4

[5]
A Compact Differential Dynamic Microscopy-based Device (cDDM): An Approach Tool for Early Detection of Hypercoagulable State in Transfusion-Dependent-β-Thalassemia Patients.

ACS Appl Bio Mater. 2024-7-15

[6]
[Hemorheological investigations in experimental surgery].

Magy Seb. 2013-6

[7]
[Significance of the markers of endothelial dysfunction and hemorheological disorders for assessing the activity and prognosis of chronic glomerulonephritis].

Ter Arkh. 2010

[8]
Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia.

Haematologica. 2011-7-26

[9]
Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules.

Acta Haematol. 2004

[10]
Hemorheology, ankle brachial pressure index (ABPI) and toe brachial pressure index (TBPI) in metabolic syndrome.

Microvasc Res. 2014-9

引用本文的文献

[1]
Coagulation and Fibrinolysis Dysregulation in β-Thalassemia Major: Potential Impact of Splenectomy and Medications on Thrombotic Risk.

Clin Appl Thromb Hemost. 2025

[2]
The Relevance of Endothelial Dysfunction Biomarkers in Thalassemia Patients and Healthy Individuals: A Systematic Review and Meta-Analysis.

Int J Mol Sci. 2025-4-18

[3]
Exploring the functional and immune landscape of E-β thalassemia patients through RNA sequencing of peripheral blood mononuclear cells.

Heliyon. 2024-12-14

[4]
Effects of Thalidomide on Endothelial Activation and Stress Index in Children with β-Thalassemia Major.

Mediterr J Hematol Infect Dis. 2024-11-1

[5]
Impact of met-haemoglobin and oxidative stress on endothelial function in patients with transfusion dependent β-thalassemia.

Sci Rep. 2024-10-25

[6]
Multidisciplinary approaches to study anaemia with special mention on aplastic anaemia (Review).

Int J Mol Med. 2024-11

[7]
A Compact Differential Dynamic Microscopy-based Device (cDDM): An Approach Tool for Early Detection of Hypercoagulable State in Transfusion-Dependent-β-Thalassemia Patients.

ACS Appl Bio Mater. 2024-7-15

[8]
The Effects and Safety of Silymarin on β-thalassemia in Children and Adolescents: A Systematic Review based on Clinical Trial Studies.

Rev Recent Clin Trials. 2024

[9]
HLA haplotype frequencies and diversity in patients with hemoglobinopathies.

EJHaem. 2023-8-4

本文引用的文献

[1]
Circulating Soluble CD163, Associations With Cardiovascular Outcomes and Mortality, and Identification of Genetic Variants in Older Individuals: The Cardiovascular Health Study.

J Am Heart Assoc. 2022-11

[2]
Phenotypical and functional abnormalities of circulating neutrophils in patients with β-thalassemia.

Ann Hematol. 2020-8-15

[3]
Hemorheological Alterations and Oxidative Damage in Sickle Cell Anemia.

Front Mol Biosci. 2019-12-4

[4]
Blood rheology in children with the S/β+-thalassemia syndrome.

Clin Hemorheol Microcirc. 2018

[5]
Update on thalassemia diagnosis: New insights and methods.

Talanta. 2018-2-20

[6]
Hypercoagulability and Vascular Disease.

Hematol Oncol Clin North Am. 2018-4

[7]
Clinical Complications and Their Management.

Hematol Oncol Clin North Am. 2018-4

[8]
Thalassaemia.

Lancet. 2017-7-31

[9]
Thermogravimetric analysis coupled with chemometrics as a powerful predictive tool for ß-thalassemia screening.

Talanta. 2016-6-21

[10]
High incidence of silent cerebral infarcts in adult patients with beta thalassemia major.

Thromb Res. 2016-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索